Categories: HealthcareNews

Inari Medical to Present at the J.P. Morgan Healthcare Conference

IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today that its management team is scheduled to present at the J.P. Morgan Healthcare Conference on Wednesday, January 15 at 8:15 a.m. Pacific Time.

Interested parties may access a live webcast and replay of the presentation by visiting the Inari Medical investor relations website.

About Inari Medical, Inc.
Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous thromboembolism and four other targeted disease states. We are just getting started. Learn more at www.inarimedical.com and connect with us on LinkedIn, X (Twitter), and Instagram.

Inari Medical contact:
Neil Bhalodkar
IR@inarimedical.com

Staff

Recent Posts

Nauticus Robotics Announces Timing of 2024 Investor Earnings Conference Call

HOUSTON, April 11, 2025 /PRNewswire/ -- Nauticus Robotics, Inc. ("Nauticus" or "Company") (NASDAQ: KITT) today…

5 hours ago

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation…

11 hours ago

STAGO ANNOUNCES “THE IMPORTANCE OF ROUTINE COAGULATION TESTING” EDUCATIONAL WEBINAR

PARSIPPANY, N.J., April 11, 2025 /PRNewswire/ -- Diagnostica Stago, Inc., a global leader in hemostasis…

11 hours ago

NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

The Company Expects the Continued Sale of OPKO-Branded Products in China but is Pausing Activities…

11 hours ago

Hamamatsu Photonics and Sirona Dx (SDX) Announce Strategic Partnership to Expand Technology Access Program (TAP)

BRIDGEWATER, N.J., April 11, 2025 /PRNewswire/ -- Hamamatsu Photonics, a global leader in whole slide…

11 hours ago

ProviderTrust Celebrates 15 Years of Innovation and Looks Ahead to the Future of Provider Data

NASHVILLE, Tenn., April 11, 2025 /PRNewswire/ -- Entering its 15th year, ProviderTrust continues to lead…

11 hours ago